The Journal of Immunology, Vol 151, Issue 3 1562-1570, Copyright © 1993 by American Association of Immunologists

ARTICLES

Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins

F Tedesco, G Narchi, O Radillo, S Meri, S Ferrone and C Betterle
Istituto di Patologia Generale, Universita di Trieste, Italy.

The susceptibility of trophoblast to cytolysis by human complement was investigated using cells purified to over 90% from first trimester placentae. Two assay systems were employed to measure the killing of trophoblasts, an antibody-dependent complement-mediated cytolysis and the reactive lysis. The antibody obtained from a patient with Addison's disease reacted specifically with syncytiotrophoblasts and induced a dose-dependent killing of the cells not exceeding 50% even in the presence of excess antibody and complement. The percentage of cells killed by the terminal complement complex in the reactive lysis system was somewhat higher, reaching values of 60%. Immunofluorescence analysis revealed the presence of CD46 and CD59 on all syncytiotrophoblasts, whereas CD55 was only detected on approximately 30% of the cells. Inhibition of CD46 and CD59 resulted in increased susceptibility of syncytiotrophoblasts to complement lysis. The protective function of CD55 could not be evaluated because of its reduced expression on isolated trophoblasts. These results suggest that syncytiotrophoblasts may be killed by complement and that membrane regulators to some extent protect these cells from complement damage.

This article has been cited by other articles:

				P. Spessotto, R. Bulla, C. Danussi, O. Radillo, M. Cervi, G. Monami, F. Bossi, F. Tedesco, R. Doliana, and A. Colombatti EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall J. Cell Sci., November 1, 2006; 119(21): 4574 - 4584. [Abstract] [Full Text] [PDF]

				R Bulla, F Fischetti, F Bossi, and F Tedesco Feto-maternal immune interaction at the placental level Lupus, September 1, 2004; 13(9): 625 - 629. [Abstract] [PDF]

				M. G. Petroff, L. Chen, T. A. Phillips, D. Azzola, P. Sedlmayr, and J. S. Hunt B7 Family Molecules Are Favorably Positioned at the Human Maternal-Fetal Interface Biol Reprod, May 1, 2003; 68(5): 1496 - 1504. [Abstract] [Full Text] [PDF]

				J E Salmon, G Girardi, and V M Holers Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis Ann Rheum Dis, November 1, 2002; 61(90002): ii46 - 50. [Full Text] [PDF]

				V. M. Holers, G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando, et al. Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss J. Exp. Med., January 22, 2002; 195(2): 211 - 220. [Abstract] [Full Text] [PDF]

				A.P. Adams and D.F. Antczak Ectopic Transplantation of Equine Invasive Trophoblast Biol Reprod, March 1, 2001; 64(3): 753 - 763. [Abstract] [Full Text]

				S. W. Kauma, T. F. Huff, N. Hayes, and A. Nilkaeo Placental Fas Ligand Expression Is a Mechanism for Maternal Immune Tolerance to the Fetus J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2188 - 2194. [Abstract] [Full Text]

				I. K. Zarkadis, A. Omigbodun, A. Forson, P. Ziolkiewicz, T. Kinoshita, J. D. Lambris, and C. Coutifaris Differentiation-Dependent Changes in Human Trophoblast Expression of Decay-Accelerating Factor Are Modulated by 3',5' Cyclic Adenosine Monophosphate Reproductive Sciences, January 1, 1997; 4(1): 47 - 53. [Abstract] [PDF]